Influence of chronic captopril therapy on the infarcted
left ventricle of the rat
J.M. Pfeffer, M.A. Pfeffer, E. Braunwaldd
Ligation of the left anterior descending artery of
the anesthetized rat to produce a variable-sized
myocardial infarction of the left ventricle,
though first described by Fishbein in 1978,
has become known to many as the "Pfeffer
model."...
Angiotensin I converting enzyme inhibitors and cardiac remodeling
C. Van Krimpen, R.G. Schoemaker, J.P.M. Cleutjens, J.F.M. Smits, H.A.J. Struyker-Boudier, F.T. Bosman,
M.J.A.P. Daemen
One of the main controversies to emerge from
the mortality trials of ACE inhibition after
myocardial infarction stems from the findings
of CONSENSUS II (COoperative North
Scandinavian ENalapril SUrvival Study II)...
Pathological hypertrophy and cardiac interstitium:
fibrosis and renin-angiotensin-aldosterone system
K.T. Weber, C.G. Brilla
Cardiologists are renowned for their focus on
a single organ often to the exclusion of other
vital related structures...
Effect of captopril on mortality and morbidity in patients with
left ventricular dysfunction after myocardial infarction.
Results of the Survival and Ventricular Enlargement Trial
M.A. Pfeffer, E. Braunwald, L.A. Moyé, and the SAVE Investigators
The SAVE (Survival And Ventricular Enlargement)
trial, led by Marc Pfeffer and Eugene Braunwald,
represents a landmark investigation for a
number of reasons...
Cells expressing angiotensin II receptors in fibrous tissue
of rat heart
Y. Sun, K.T. Weber
Angiotensin II has been implicated in systemic
hypertension and the death of patients with
heart failure and after acute myocardial
infarction...
Structural basis of end-stage failure in ischemic cardiomyopathy
in humans
C.A. Beltrami, N. Finato, M. Rocco, G.A. Feruglio, C. Puricelli, E. Cigola, F. Quaini, E.H. Sonnenblick,
G. Olivetti, P. Anversa
Loss of irreplaceable cardiomyocytes is a key
etiological factor in the development of heart
failure, irrespective of whether it is classified
as being of ischemic or nonischemic origin...
Collagen remodeling after myocardial infarction in the rat heart
J.P.M. Cleutjens, M.J.A. Verluyten, J.F.M. Smits, M.J.A.P. Daemen
Within the myocardium, interstitial collagen
networks are composed largely of type I
and III fibrillar subtypes, which help to
preserve tissue architecture and chamber
geometry, while also being the major
determinant of wall stiffness...
Angiotensin converting enzyme and myofibroblasts during tissue
repair in the rat heart
Y. Sun, K.T. Weber
This study was designed to determine whether
collagen-producing phenotypically modulated
fibroblasts (myofibroblasts, myoFbs) were
present following experimentally-induced
myocardial infarction and following pericardectomy
within the visceral pericardium as it healed
by fibrosis...
Angiotensin II receptor blockade after myocardial infarction
in rats: effects on hemodynamics, myocardial DNA synthesis,
and interstitial collagen content
J.F.M. Smits, C. Van Krimpen, R.G. Schoemaker, J.P.M. Cleutjens, M.J.A.P. Daemen
Cardiac remodeling represents an alteration in
the geometry of the heart, which may act as
an adaptive or a pathological process...
Fibrosis, a common pathway to organ failure: angiotensin II
and tissue repair
K.T. Weber
In an earlier review (see page 46), I commented on
the role that the work of Karl Weber’s group may
have had in expanding the horizons of cardiologists
and cardiovascular physicians beyond cardiomyocytes,
the heart, and the cardiovascular system...
|